Investigation of preference, clinical efficacy and trough concentration of vedolizumab by patient-oriented switching to intravenous (IV) or subcutaneous (SC) injection in patients with ulcerative colitis

Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2024
This article has no abstract
Epistemonikos ID: 720890fbef725e7519cc0e97c5a9935adc4f4cf4
First added on: Apr 09, 2025